Literature DB >> 1655059

Methods for detection and frequency of contamination of fetal calf serum with bovine viral diarrhea virus and antibodies against bovine viral diarrhea virus.

S R Bolin1, P J Matthews, J F Ridpath.   

Abstract

Methods used by the National Animal Disease Center to test fetal calf serum for contamination with bovine viral diarrhea virus (BVDV) and antibodies against BVDV are described. Using those methods, virus was isolated from 332 of 1,608 (20.6%) lots of raw fetal calf serum obtained specifically for the Center and 93 of 190 (49%) lots of commercially available fetal calf serum. Virus neutralization and immunoperoxidase staining tests were used to detect antibodies against BVDV in 224 of the 1,608 (13.9%) lots of raw fetal calf serum. Both BVDV and antibodies against BVDV were detected in 50 lots of raw serum. The molecular specificity of antibodies against BVDV was determined by radioimmunoprecipitation. Lots of fetal calf serum that contained BVDV-specific antibodies that did not neutralize virus were identified.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655059     DOI: 10.1177/104063879100300302

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  24 in total

1.  Collective experiences of adventitious viruses of animal-derived raw materials and what can be done about them.

Authors:  S J Wessman; R L Levings
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

Review 2.  Bladder biomechanics and the use of scaffolds for regenerative medicine in the urinary bladder.

Authors:  Fatemeh Ajalloueian; Greg Lemon; Jöns Hilborn; Ioannis S Chronakis; Magdalena Fossum
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

3.  Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay.

Authors:  R W Fulton; J T Saliki; L J Burge; J M d'Offay; S R Bolin; R K Maes; J C Baker; M L Frey
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

4.  Comparison of nucleic acid hybridization and nucleic acid amplification using conserved sequences from the 5' noncoding region for detection of bovine viral diarrhea virus.

Authors:  J F Ridpath; S R Bolin; J Katz
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

5.  Bladder tissue regeneration using acellular bi-layer silk scaffolds in a large animal model of augmentation cystoplasty.

Authors:  Duong D Tu; Yeun Goo Chung; Eun Seok Gil; Abhishek Seth; Debra Franck; Vivian Cristofaro; Maryrose P Sullivan; Dolores Di Vizio; Pablo Gomez; Rosalyn M Adam; David L Kaplan; Carlos R Estrada; Joshua R Mauney
Journal:  Biomaterials       Date:  2013-08-13       Impact factor: 12.479

6.  Microtiter virus isolation and enzyme immunoassays for detection of bovine viral diarrhea virus in cattle serum.

Authors:  J T Saliki; R W Fulton; S R Hull; E J Dubovi
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

7.  Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease.

Authors:  S R Bolin; J F Ridpath
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Rapid detection of bovine viral diarrhea virus by using RNA extracted directly from assorted specimens and a one-tube reverse transcription PCR assay.

Authors:  A L Hamel; M D Wasylyshen; G P Nayar
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

9.  Experimental infection of calves with bovine viral diarrhoea virus type-2 (BVDV-2) isolated from a contaminated vaccine.

Authors:  E Falcone; P Cordioli; M Tarantino; M Muscillo; G Sala; G La Rosa; I L Archetti; C Marianelli; G Lombardi; M Tollis
Journal:  Vet Res Commun       Date:  2003-10       Impact factor: 2.459

10.  Characterization of early pathogenic effects after experimental infection of calves with bovine immunodeficiency-like virus.

Authors:  S Carpenter; L D Miller; S Alexandersen; C A Whetstone; M J VanDerMaaten; B Viuff; Y Wannemuehler; J M Miller; J A Roth
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.